Omeprazole Pellets / Micro-Pellets
Omeprazole Pellets 8.5%, 10%, 20%, 22%, 22.5%, 30% – Suitable for Capsules (Dose: 10 mg, 20 mg, 40 mg)
Omeprazole is a widely used proton pump inhibitor (PPI) that works by decreasing the amount of acid produced in the stomach. It is used for the treatment of peptic ulcers, GERD, and related acid-related conditions.
- Developed using aqueous technology.
- Available in pellet sizes suitable for capsules, suspension, or tablet compression.
- DMF file submitted to USFDA and EDMF submitted to National Authorities in Greece and Romania (currently under review).
- Products protected by ongoing patents are not offered.
Omeprazole commands a market size of $7 billion and is marketed as an enteric release formulation. Murli Krishna Pharma Pvt. Ltd. is a leading global Active Pharmaceutical Ingredients (API) manufacturer and supplier for Omeprazole API. The product is offered as a semi-finished formulation in a pelletized form. Omeprazole API is manufactured under a strict control with stringent specifications on the impurity profile as well as the particle size not to mention, the use of correct polymorphs also. The excipients used are specifically chosen and are non-infringing. The product can also be offered in a pellet size suitable for use in a suspension or for compression in tablets.
Additional Information
| Percentage | 8.5%, 10%, 20%, 22%, 22.5%, 30% |
|---|---|
| Mesh Size | 12#16, 12#14, 14#18, 16# 20, 18#20, 20#24, 24#30, 30#40, 40#60 |
| Release Type | Delayed Release |
| Quality Standard | USP43 |
| Documentation Available: | DMF in CTD Format |
| Forms of PFI | Pellets/Micro pellets (for capsules) |
| Target Formulations | Capsules, Tablets |
